1.965
6.43%
-0.135
Cocrystal Pharma Inc 주식(COCP)의 최신 뉴스
Swiss National Bank Has $6.76 Million Stock Position in Itron, Inc. (NASDAQ:ITRI) - Defense World
Defense World
Cocrystal Pharma (NASDAQ:COCP) Given Buy Rating at HC Wainwright - Defense World
Defense World
New York State Common Retirement Fund Has $335000 Stake in Brandywine Realty Trust (NYSE:BDN) - Defense World
Defense World
Russell Investments Group Ltd. Purchases 129182 Shares of Gambling.com Group Limited (NASDAQ:GAMB) - Defense World
Defense World
Cocrystal Pharma and RFS Pharma Merge to Create Advanced Antiviral Development Organization - Yahoo Eurosport UK
Yahoo Eurosport UK
Influenza Pipeline Assessment, 2024 Updates: FDA, EMA, and PMDA Approvals, Emerging Drugs, Clinical Trials, and ... - openPR
openPR
Cocrystal Pharma stock maintains price target, Outperform rating - Investing.com Canada
Investing.com Canada
Cocrystal Pharma Reports First Quarter 2024 Financial Results and Provides Updates on its Antiviral Drug ... - wallstreet:online
wallstreet:online
Cocrystal Pharma Receives Investment Through Private Placement - Yahoo News UK
Yahoo News UK
Hepatitis C Market Forecast 2032: FDA, EMA, PDMA Approvals, Epidemiology, Therapies, Clinical Trials and ... - openPR
openPR
Closing Bell: TD Global Healthcare Leaders Index ETF up on Tuesday (TDOC) - The Globe and Mail
The Globe and Mail
Influenza Pipeline Analysis 2024: FDA Approvals, Clinical Trials, Therapies, Mechanism of Action, Route of ... - openPR
openPR
Cocrystal Pharma Advances Promising Influenza A Drug - TipRanks.com - TipRanks
TipRanks
Columbia Banking System, Inc. (NASDAQ:COLB) Given Average Recommendation of “Hold” by Analysts - Defense World
Defense World
Zacks Research Brokers Cut Earnings Estimates for Murphy USA Inc. (NYSE:MUSA) - Defense World
Defense World
COCP: Topline Data for Influenza A and Dual Coronavirus/Norovirus Programs Expected in 2024; Model Revision ... - Zacks Small Cap Research
Zacks Small Cap Research
Cocrystal Pharma Reports 2023 Financial Results and Provides Updates on its Antiviral Drug-Development Programs
GlobeNewswire Inc.
Cocrystal Pharma Advances Influenza A Treatment Development - TipRanks.com - TipRanks
TipRanks
Cocrystal Pharma Receives Pre-IND Responses from the FDA on Oral CC-42344 for Treating Influenza A
GlobeNewswire Inc.
The Anticipated Breakthrough: The Race for a Norovirus Vaccine - Medriva
Medriva
ClinConnect Partners with Conduit Pharmaceuticals on Cocrystal Development Program for AZD1656 - Business Wire
Business Wire
CDI-988 enters development as oral norovirus therapy - BioWorld Online
BioWorld Online
Cocrystal formation of niclosamide and urea in supercritical CO2 and impact of cosolvent - ScienceDirect.com
ScienceDirect.com
Cocrystal receives approval for Phase I trial of Covid-19 therapy - Clinical Trials Arena
Clinical Trials Arena
Appellate court rules against Liberty Mutual unit in D&O litigation - Business Insurance
Business Insurance
Cocrystal Pharma and MSD patent describes influenza virus CEN inhibitors - BioWorld Online
BioWorld Online
Theratechnologies Is An Underappreciated HIV-Focused Company, Analyst Says - Yahoo Finance
Yahoo Finance
Adjusting the melting point of an Active Pharmaceutical Ingredient (API) via cocrystal formation enables processing of ... - ScienceDirect.com
ScienceDirect.com
Influenza Pipeline Looks Promising as 100+ Companies Working in the Domain, Assesses DelveInsight - PR Newswire
PR Newswire
Kowa Pharmaceuticals America,Inc. Announces Publication of Phase 3 Data Supporting FDA Approval of SEGLENTIS ... - Business Wire
Business Wire
Hepatitis C Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - GlobalData
GlobalData
Influenza A Virus, H1N1 Subtype Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and ... - GlobalData
GlobalData
Full data published on Evusheld, Astrazeneca's 'last MAb standing' in COVID-19 - BioWorld Online
BioWorld Online
FDA Issues Complete Response Letter to Iterum Therapeutics plc (NASDAQ: ITRM) On Its NDA for Oral Sulopenem - BP Journal
BP Journal
Supplements firm backed by Mark Zuckerberg 'pure hype': short seller - New York Post
New York Post
Gilead's Kite Pharma Collaborates With Shoreline Biosciences For Cell Therapies For Cancer Settings - Yahoo Finance
Yahoo Finance
eToro issues statement on closing of positions - FX News Group
FX News Group
Cocrystal Pharma Inc (NASDAQ:COCP) Reveals Promising Toxicity Data From Its CC-42344 Lead Molecule Against ... - BP Journal
BP Journal
Cocrystal Pharma raises "bought deal" offering to $15M (NASDAQ:COCP) - Seeking Alpha
Seeking Alpha
Aileron Therapeutics Inc (NASDAQ:ALRN) Raises $10.3 Million: Develops Innovative Medicine To Safeguard Cancer ... - BP Journal
BP Journal
Cocrystal Pharma Files For $150 Mln Mixed Shelf Offering - SEC Filing - Reuters
Reuters
Covid-19: Partnerships for coronavirus vaccines development - Pharmaceutical Technology
Pharmaceutical Technology
KSU licenses technology for coronavirus, norovirus compounds - Salina Post
Salina Post
18 Medical Stocks To Watch Amid The Coronavirus Outbreak - Novavax (NASDAQ:NVAX), Inovio Pharmaceuticals - Benzinga
Benzinga
Emory HIV/AIDS drug inventor, entrepreneur decorated with French Legion of Honor - Emory News Center
Emory News Center
Ex-Teva Chairman, Blockchain Investor Accused of Pump-and-Dump Scheme - The Wall Street Journal
The Wall Street Journal
Insoluble drug delivery strategies: review of recent advances and business prospects - ScienceDirect.com
ScienceDirect.com
Jane Hsiao Net Worth - TheRichest
TheRichest
Institute of Human Virology honors Schinazi with Lifetime Achievement Award - Emory News Center
Emory News Center
자본화:
|
볼륨(24시간):